Bayer to Use Tobacco for Tailor-Made Drugs

Bayer AG. has said it intends to conduct tests on humans next year using drugs that have been produced from tobacco plants and that have been modified to meet patients' individual needs, according to a Thomson Financial News report. Yesterday, Bayer inaugurated a production facility in Halle, Germany, which will be operated by its subsidiary, Icon Genetics. Enditem